asthma

News

RAPT hit by FDA clinical hold on eczema, asthma drug

RAPT Therapeutics has seen its shares fall sharply after the FDA placed a clinical hold on oral CCR4 antagonist zelnecirnon, currently in a phase 2b trial for atopic derma

News

JPM: GSK announces $1.4bn deal to buy asthma biotech Aiolos

GSK has taken another step towards rebuilding its respiratory pipeline with a $1.4 billion agreement to buy Aiolos Bio and its lead drug AIO-001 for asthma and other indic

News

Lack of lung disease testing causing ‘avoidable harm’ in NHS

A patient organisation in the UK has said that a lack of basic testing for lung conditions like asthma in primary care is leading to many people remaining undiagnosed, add

News

Digital health app Juli shows worth in asthma, depression

Juli, an artificial intelligence-powered platform to help people manage chronic health conditions, has been shown to improve outcomes in a pair of randomised clinical tria

News

Teva’s smart inhaler launches in first European market

Teva has launched a digitally-enabled inhaler in the UK, the first European market for the device, for use by patients with asthma and chronic obstructive pulmonary disord

News

EU clears AstraZeneca's new-form severe asthma drug Tezspire

AstraZeneca's first-in-class severe asthma therapy Tezspire has been approved in the EU in a new pen injector formulation suitable for administration by patients themselves.

RAPT hit by FDA clinical hold on eczema, asthma drug

JPM: GSK announces $1.4bn deal to buy asthma biotech Aiolos

Lack of lung disease testing causing ‘avoidable harm’ in NHS

Digital health app Juli shows worth in asthma, depression

Teva’s smart inhaler launches in first European market

EU clears AstraZeneca's new-form severe asthma drug Tezspire

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

asthma

Editor's Picks